200 related articles for article (PubMed ID: 22241999)
1. Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liver.
Xu RH; Rubio D; Roscoe F; Krouse TE; Truckenmiller ME; Norbury CC; Hudson PN; Damon IK; Alcamí A; Sigal LJ
PLoS Pathog; 2012 Jan; 8(1):e1002475. PubMed ID: 22241999
[TBL] [Abstract][Full Text] [Related]
2. The Pathogenesis and Immunobiology of Mousepox.
Sigal LJ
Adv Immunol; 2016; 129():251-76. PubMed ID: 26791861
[TBL] [Abstract][Full Text] [Related]
3. A homolog of the variola virus B22 membrane protein contributes to ectromelia virus pathogenicity in the mouse footpad model.
Reynolds SE; Earl PL; Minai M; Moore I; Moss B
Virology; 2017 Jan; 501():107-114. PubMed ID: 27898336
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interferons by ectromelia virus.
Smith VP; Alcami A
J Virol; 2002 Feb; 76(3):1124-34. PubMed ID: 11773388
[TBL] [Abstract][Full Text] [Related]
5. The mature virion of ectromelia virus, a pathogenic poxvirus, is capable of intrahepatic spread and can serve as a target for delayed therapy.
Ma X; Xu RH; Roscoe F; Whitbeck JC; Eisenberg RJ; Cohen GH; Sigal LJ
J Virol; 2013 Jun; 87(12):7046-53. PubMed ID: 23596297
[TBL] [Abstract][Full Text] [Related]
6. Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection.
Sakala IG; Chaudhri G; Eldi P; Buller RM; Karupiah G
PLoS One; 2015; 10(3):e0118685. PubMed ID: 25751266
[TBL] [Abstract][Full Text] [Related]
7. The ectromelia virus SPI-2 protein causes lethal mousepox by preventing NK cell responses.
Melo-Silva CR; Tscharke DC; Lobigs M; Koskinen A; Wong YC; Buller RM; Müllbacher A; Regner M
J Virol; 2011 Nov; 85(21):11170-82. PubMed ID: 21849445
[TBL] [Abstract][Full Text] [Related]
8. Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection.
Kaminsky LW; Sei JJ; Parekh NJ; Davies ML; Reider IE; Krouse TE; Norbury CC
J Virol; 2015 Oct; 89(19):9974-85. PubMed ID: 26202250
[TBL] [Abstract][Full Text] [Related]
9. N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.
Gratz MS; Suezer Y; Kremer M; Volz A; Majzoub M; Hanschmann KM; Kalinke U; Schwantes A; Sutter G
J Virol; 2011 Apr; 85(7):3557-69. PubMed ID: 21270149
[TBL] [Abstract][Full Text] [Related]
10. The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.
Xu RH; Cohen M; Tang Y; Lazear E; Whitbeck JC; Eisenberg RJ; Cohen GH; Sigal LJ
J Exp Med; 2008 Apr; 205(4):981-92. PubMed ID: 18391063
[TBL] [Abstract][Full Text] [Related]
11. A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.
Alejo A; Saraiva M; Ruiz-Argüello MB; Viejo-Borbolla A; de Marco MF; Salguero FJ; Alcami A
PLoS One; 2009; 4(4):e5175. PubMed ID: 19365546
[TBL] [Abstract][Full Text] [Related]
12. Ectromelia-encoded virulence factor C15 specifically inhibits antigen presentation to CD4+ T cells post peptide loading.
Forsyth KS; Roy NH; Peauroi E; DeHaven BC; Wold ED; Hersperger AR; Burkhardt JK; Eisenlohr LC
PLoS Pathog; 2020 Aug; 16(8):e1008685. PubMed ID: 32745153
[TBL] [Abstract][Full Text] [Related]
13. EVM005: an ectromelia-encoded protein with dual roles in NF-κB inhibition and virulence.
van Buuren N; Burles K; Schriewer J; Mehta N; Parker S; Buller RM; Barry M
PLoS Pathog; 2014 Aug; 10(8):e1004326. PubMed ID: 25122471
[TBL] [Abstract][Full Text] [Related]
14. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
Front Immunol; 2018; 9():1297. PubMed ID: 29963044
[TBL] [Abstract][Full Text] [Related]
15. Induction of natural killer cell responses by ectromelia virus controls infection.
Parker AK; Parker S; Yokoyama WM; Corbett JA; Buller RM
J Virol; 2007 Apr; 81(8):4070-9. PubMed ID: 17287257
[TBL] [Abstract][Full Text] [Related]
16. Loss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo.
Lynn H; Horsington J; Ter LK; Han S; Chew YL; Diefenbach RJ; Way M; Chaudhri G; Karupiah G; Newsome TP
J Virol; 2012 Jul; 86(13):7427-43. PubMed ID: 22532690
[TBL] [Abstract][Full Text] [Related]
17. Obligatory requirement for antibody in recovery from a primary poxvirus infection.
Chaudhri G; Panchanathan V; Bluethmann H; Karupiah G
J Virol; 2006 Jul; 80(13):6339-44. PubMed ID: 16775322
[TBL] [Abstract][Full Text] [Related]
18. Homing studies on distribution of ectromelia (mousepox) virus-specific T cells adoptively transferred into syngeneic H-2d mice: paradigm of lymphocyte migration.
Gieryńska M; Toka FN; Cespedes IS; Schollenberger A; Malicka E; Popis A; Niemiałtowski MG
Viral Immunol; 2000; 13(1):107-23. PubMed ID: 10733173
[TBL] [Abstract][Full Text] [Related]
19. A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease.
Israely T; Paran N; Lustig S; Erez N; Politi B; Shafferman A; Melamed S
Virol J; 2012 Jun; 9():119. PubMed ID: 22709563
[TBL] [Abstract][Full Text] [Related]
20. Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.
Chaudhri G; Panchanathan V; Buller RM; van den Eertwegh AJ; Claassen E; Zhou J; de Chazal R; Laman JD; Karupiah G
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9057-62. PubMed ID: 15184649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
